Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - The Lancet Oncology
Por um escritor misterioso
Descrição
A spectroscopic liquid biopsy for the earlier detection of multiple cancer types
Multimodal cell-free DNA whole-genome analysis combined with TET-Assisted Pyridine Borane Sequencing is sensitive and reveals specific cancer signals
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study - The Lancet
Early detection of cancer
Full breakdown of STm model performance. FN, false negative; FP, false
A spectroscopic liquid biopsy for the earlier detection of multiple cancer types
Performance of the WID-qEC test versus sonography to detect uterine cancers in women with abnormal uterine bleeding (EPI-SURE): a prospective, consecutive observational cohort study in the UK - The Lancet Oncology
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study - The Lancet
The Lancet Oncology Publishes Results from SYMPLIFY, The First Prospective Study of a Multi-Cancer Early Detection Test in a Symptomatic Patient Population - GRAIL
Multimodal cell-free DNA whole-genome analysis combined with TET-Assisted Pyridine Borane Sequencing is sensitive and reveals specific cancer signals
Carli Cahill on LinkedIn: Providence and GRAIL Expand Partnership to Increase Access to Galleri®…
Multi-cancer Early Detection Test In Symptomatic Patients, 40% OFF
Triaging suspected cancer with a multi-cancer early detection blood test - The Lancet Oncology
Full article: Circulating tumor DNA (ctDNA): can it be used as a pan-cancer early detection test?
Cell-free DNA approaches for cancer early detection and interception
de
por adulto (o preço varia de acordo com o tamanho do grupo)
